Associated Papers
Role of Single Nucleotide Polymorphism L55M in the Paraoxonase 1 Gene as a Risk and Prognostic Factor in Acute Coronary Syndrome.
Doneva-Basheva KI et al.
Current Issues in Molecular Biology, 2022
Paraoxonase 1 gene polymorphisms in lipid oxidation and atherosclerosis development.
Vavlukis M et al.
Frontiers in Genetics, 2022
The Relevance of Noncoding DNA Variations of Paraoxonase Gene Cluster in Atherosclerosis-Related Diseases.
Wysocka A et al.
International Journal of Molecular Sciences, 2021
Susceptibility of PON1/PON2 Genetic Variations to Ischemic Stroke Risk in a Chinese Han Population.
Pan Y et al.
Pharmacogenomics and Personalized Medicine, 2020
The most effective polymorphisms of paraoxonase-1 gene on enzyme activity and concentration of paraoxonase-1 protein in type 2 diabetes mellitus patients and non-diabetic individuals: A systematic review and meta-analysis.
Hashemi MM et al.
Diabetes Research and Clinical Practice, 2019
Genetic polymorphisms in amyotrophic lateral sclerosis: Evidence for implication in detoxification pathways of environmental toxicants.
Dardiotis E et al.
Environment International, 2018
Paraoxonase 1 (PON1) and stroke; the dilemma of genetic variation.
Tajbakhsh A et al.
Clinical Biochemistry, 2017
Oxidative stress-related genes in type 2 diabetes: association analysis and their clinical impact.
Haldar SR et al.
Biochemical Genetics, 2015
Paraoxonase 1 genotype-phenotype correlation in patients with metabolic syndrome.
Ciumărnean L et al.
Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie, 2015
Association between PON1 rs662 polymorphism and coronary artery disease.
Liu T et al.
European Journal of Clinical Nutrition, 2014
Modulation of the endogenous antioxidants paraoxonase-1 and urate by pesticide exposure and genetic variants of xenobiotic-metabolizing enzymes.
Hernández AF et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association, 2013
Evaluation of pesticide-induced oxidative stress from a gene-environment interaction perspective.
Hernández AF et al.
Toxicology, 2013
Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease.
Mackness B et al.
Archives of Medical Science : Ams, 2013
Two- and three-locus haplotypes of the paraoxonase (PON1) gene are associated with coronary artery disease in Asian Indians.
Ahmad I et al.
Gene, 2012
Association of a protective paraoxonase 1 (PON1) polymorphism in Parkinson's disease.
Belin AC et al.
Neuroscience Letters, 2012
Low serum PON1 activity: an independent risk factor for coronary artery disease in North-West Indian type 2 diabetics.
Gupta N et al.
Gene, 2012
Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
Gupta N et al.
Gene, 2011
Frequency distribution of the single-nucleotide -108C/T polymorphism at the promoter region of the PON1 gene in Asian Indians and its relationship with coronary artery disease.
Ahmad I et al.
Journal of Community Genetics, 2011
Paraoxonase 1 (PON1) polymorphisms, haplotypes and activity in predicting cad risk in North-West Indian Punjabis.
Gupta N et al.
Plos One, 2011
Comparison of statistical models for analyzing genotype, inferred haplotype, and molecular haplotype data.
Wallenstein S et al.
Molecular Genetics and Metabolism, 2006
Roles of paraoxonase and oxidative stress in adolescents with uraemic, essential or obesity-induced hypertension.
Baráth A et al.
Kidney & Blood Pressure Research, 2006
Haplotype-phenotype relationships of paraoxonase-1.
Chen J et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2005
Paraoxonase 1 status in the Thai population.
Phuntuwate W et al.
Journal of Human Genetics, 2005
Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression.
Brophy VH et al.
American Journal of Human Genetics, 2001
Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity.
Costa LG et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals, 0
Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy.
Kovács TJ et al.
Journal of Nephrology, 0
Association between Serum Paraoxonase 1 Activities (PONase/AREase) and L55M Polymorphism in Risk of Female Infertility.
Motovali-Bashi M et al.
Avicenna Journal of Medical Biotechnology, 0